NCT06173076View on ClinicalTrials.gov

A Prospective Study to Evaluate Clinical Outcomes in Anti-LGI1 Encephalitis

RecruitingOBSERVATIONAL

Enrollment

60

Participants

Timeline

Start Date

May 18, 2022

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2032

Conditions

Autoimmune EncephalitisLeucine-Rich Glioma Inactivated 1 Autoimmune Encephalitis

Trial Locations (1)

Unknown

RECRUITING

2nd Affiliated Hospital, School of Medicine, Zhejiang University, China, Hangzhou

All Listed Sponsors

lead

Shen Chun-Hong

OTHER